RxDoctor Payments Data

Stacy Halderman

Family · Corona, CANPI 1558836510

Payments from drug & device makers

$3,803in general payments, 2019–2025

Across 191 payments — averaging $19.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$384
  • Abbott$371
  • AstraZeneca$365
  • Novo Nordisk$340
  • AbbVie$318
  • Lilly USA, LLC$206
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$3,803100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,803 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide27$38,209
EliquisApixaban38$32,980
JardianceEmpagliflozin17$22,565
FarxigaDapagliflozin Propanediol21$12,847
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$11,230
Atorvastatin Calcium178$1,766
Levothyroxine Sodium160$1,572
Albuterol Sulfate HfaAlbuterol Sulfate45$1,571
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$1,332
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen65$1,309
Losartan Potassium105$1,268
SynthroidLevothyroxine Sodium12$1,082
Famotidine50$1,012
Omeprazole54$935
Estradiol11$825

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$340$38,20927 claims
PfizerEliquis$187$32,98038 claims
Boehringer IngelheimJardiance$123$22,56517 claims
AstraZenecaFarxiga$365$12,84721 claims
GSKTrelegy Ellipta$202$11,23017 claims
AbbVieSynthroid$318$1,08212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.

Other family in Corona

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →